Fig. 1From: CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapyRepresentative images of the immunohistochemical findings (membrane and citoplasmatic expressions) for the different metabolism-related proteins in breast cancer samples. a MCT1; b MCT4; c CD147; d GLUT1; e CAIXBack to article page